高级检索
当前位置: 首页 > 详情页

Diagnostic Ureteroscopy Prior to Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma Increased the Risk of Intravesical Recurrence.

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Urology, West China Hospital, Sichuan University, Chengdu, China [2]Institute of Urology, West China Hospital, Sichuan University, Chengdu, China [3]Department of Emergency, West China Hospital, Sichuan University, Chengdu, China
出处:
ISSN:

关键词: Upper urinary tract Urothelial carcinoma Ureteroscopy Intravesical recurrence Nephroureterectomy

摘要:
To assess the impact of diagnostic ureteroscopy (URS) prior to radical nephroureterectomy (RNU) on intravesical recurrence (IVR) in patients with upper tract urothelial carcinoma (UTUC). A systematic literature search of the Medline, Embase, PubMed, and Cochrane library was performed in August 2017. Cumulative analyses of available hazard ratios (HRs) and their 95% CI were conducted using Stata version 12.0. Eleven studies including 4,057 participants were included, with a total of 1,403 patients diagnosed with IVR during the follow-up period. The pooled HRs of eight studies suggested that diagnostic URS prior to RNU significantly increased the IVR risk after RNU (HR 1.53, 95% CI 1.31-1.77; p < 0.001). However, the preoperative diagnostic URS was not associated with cancer-specific survival (HR 0.72; p = 0.11), metastasis-free survival (HR 1.09; p = 0.60) or overall survival (HR 1.12; p = 0.73). No publication bias was observed (Begg, p = 0.90; Egger, p = 0.71). Regardless, the diagnostic URS prior to RNU might increase the IVR risk in patients with UTUC. As ureteroscopy provides important prognostic and therapeutic value and guides decisions in UTUC, more future studies should be performed to find a novel way to mitigate the potential risk of IVR after RNU, such as chemoprophylaxis after endoscopy. © 2017 S. Karger AG, Basel.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 4 区 医学
小类 | 4 区 泌尿学与肾脏学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 泌尿学与肾脏学
第一作者:
第一作者机构: [1]Department of Urology, West China Hospital, Sichuan University, Chengdu, China [2]Institute of Urology, West China Hospital, Sichuan University, Chengdu, China
共同第一作者:
通讯作者:
通讯机构: [1]Department of Urology, West China Hospital, Sichuan University, Chengdu, China [2]Institute of Urology, West China Hospital, Sichuan University, Chengdu, China [*1]Department of Urology, West China Hospital, Sichuan University Institute of Urology, West China Hospital, Sichuan University, Number 37 Guoxue Alley, Chengdu, Sichuan 610041 (China)
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43377 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号